drugset / Trial / NCT05762458

The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

NCT05762458

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression.

Timeline

Start
2023-02-28
Primary completion
2024-05-15
Completion
2024-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Ammoxetine Unknown 40 mg
Subject Ammoxetine Unknown 60 mg